Authored by Lance Roberts via RealInvestmentAdvice.com, It’s that time of year when Wall Street polishes up its crystal balls and begins predicting returns for 2026. Since Wall Street never predicts a down year, which would be unwise for fee-based product revenues, these forecasts are often inaccurate and sometimes significantly wrong. Let’s review some previous years. […]

Shares of warship builder Huntington Ingalls Industries rose in premarket trading and are on track for the largest annual gain in 12 years, driven by news of President Trump’s continued push to rebuild the U.S. Navy. HII gained 5% on Monday and another 5% in premarket trading early Tuesday after President Trump announced a plan […]

Fueling The Conversation, Week of December 23rd, 2025 During this holiday season, it’s important to take a moment to be grateful for the things that matter most in life: family, friends, and the comforts of home. And there’s one more thing that matters – reliable and affordable energy. But enjoying the holidays has gotten a […]

Novo Nordisk shares in Europe jumped the most in nearly two years after the U.S. FDA approved the Wegovy pill, a once-daily 25 mg oral semaglutide, for long-term weight loss, weight maintenance, and reduction of major adverse cardiovascular events. The approval marks a much-needed win for the struggling Danish pharmaceutical company, which has been hit […]

Prior to the release of “Avatar: Fire and Ash” in the week before Christmas, 2025 was another disappointing year at the box office. Statista’s Felix Richer details below that, according to industry tracker The Numbers, this year’s domestic box office gross will be roughly in line with last year’s result, which fell short of the 2023 […]